๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Morphologic types of diffuse large-cell lymphoma

โœ Scribed by Roger A. Warnke; James A. Strauchen; Jerome S. Burke; Richard T. Hoppe; Bruce A. Campbell; Ronald F. Dorfman


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
464 KB
Volume
50
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


One hundred eighty-seven patients with confirmed diffuse non-Hodgkin's lymphoma were selected from a consecutive series of 391 patients who were evaluated and treated a t Stanford University Medical Center. Lymphomas with any degree of nodularity and diffuse lymphomas of "well-differentiated" and "poorly differentiated" lymphocytic type were excluded from this study. Each of four observers identified cases of diffuse large-cell lymphoma from the 187 cases and further subdivided these cases into six morphologic types in accordance with criteria proposed by Strauchen et al.' Initial intraobserver and interobserver agreement was relatively low but was greatly enhanced when the initial six morphologic types were grouped as either follicular center-cell or nonfollicular center-cell types. When individual observer results were pooled, statistically significant differences were seen between survival of patients in these two groups, with the patients in the nonfollicular center-cell group having a worse prognosis (P = 0.04). This effect of morphologic type appeared to be independent of pathologic stage. Mitotic counts did not correlate with survival.


๐Ÿ“œ SIMILAR VOLUMES


Spontaneous remission in diffuse large c
โœ Jean L. Grem; Gholam R. Hafez; James H. Brandenburg; Paul P. Carbone ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 354 KB ๐Ÿ‘ 2 views

A case of spontaneous remission in a Stage IIA diffuse large cell lymphoma is presented. Review of the literature suggests that whereas spontaneous regressions are a well-recognized phenomenon in indolent lymphomas, it is extremely rare in lymphomas of aggressive histologic subtype.

Symptomatic intracardiac diffuse large B
โœ Makiko Ban-Hoefen; Steven H. Bernstein; John D. Bisognano; Jennifer G. Pryor; Jo ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB ๐Ÿ‘ 1 views
Prognostic models for diffuse large b-ce
โœ Annarita Conconi; Emanuele Zucca; Enrico Roggero; Francesco Bertoni; Augusto Ber ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

Prognosis of DLCL patients is variable and associated with well-deยฎned risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an internation

Characteristics of diffuse large B cell
โœ Eva Baecklund; Carin Backlin; Anastasia Iliadou; Fredrik Granath; Anders Ekbom; ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) are at increased risk of malignant lymphomas, with a correlation between RA disease severity and lymphoma risk, most pronounced for diffuse large B cell lymphomas (DLBCLs), which also constitute the majority of RAโ€associated lymphoma